Microvascular brain health and speech in people at risk for Alzheimer’s disease
Official title: Microvascular hemodynamics and speech function in adults at risk for Alzheimer's disease
Funded at Mgh Institute of Health Professions · NIH-11360881 · Data updated 2026-11-12
This study will look at how tiny blood vessels in the brain relate to speech and thinking changes in adults at risk for Alzheimer’s disease.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mgh Institute of Health Professions NIH-funded |
| Lab location | 1 site (Charlestown, UNITED STATES) |
| Project start | June 1, 2026 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $624,208 |
| NIH project number | 1R15AG101712-01 |
| Project ID | NIH-11360881 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults aged 65 and older who are at risk for Alzheimer's disease, including those with APOE-ε4 genetic risk.
✕Less likely to help
People without risk factors or who cannot undergo MRI may not directly benefit.
What this research studies
If you are 65 or older and have risk factors for Alzheimer’s disease, researchers will use noninvasive brain imaging and speech measurements to explore how blood flow in the brain relates to how you speak and move. They will analyze acoustic and movement data from speech alongside MRI-based measures of cerebral blood flow to see if patterns differ by genetic risk (APOE-ε4). The goal is to identify early, easy-to-measure signals that could indicate who is at higher risk before more obvious symptoms appear. Participation would involve visits for MRI scans and simple speech tasks. This work could pave the way for earlier detection and monitoring of brain health in aging adults at risk for AD.
Why it matters
Potential benefit: If successful, it could lead to earlier detection of Alzheimer’s risk and development of noninvasive biomarkers based on speech and brain blood flow.
How similar studies have gone: Prior work suggests speech metrics can reflect early neurodegenerative changes, but combining with microvascular measures is a newer approach.
Where this research is happening
-
Mgh Institute of Health Professions
Charlestown, United States Active
Researchers
- Principal investigator: Eshghi, Marziye — Mgh Institute of Health Professions
- Study coordinator: Eshghi, Marziye
Related research
Other NIH-funded projects on the same topics.
-
Everyday speech tests to detect and monitor Alzheimer’s and related dementias
This project uses short recorded speech on phones to look for early signs of Alzheimer’s and track language changes over time.
-
Using digital speech analysis to detect Alzheimer's disease early.
This study is looking at how everyday speech can help spot early signs of Alzheimer's and related dementias, using recordings and smart technology, to make it easier for people, especially those from underserved communities, to get involved in research and understand how the disease progresses.
-
Using speech patterns to find early signs of Alzheimer's disease
This study is looking at how changes in speech can help spot early signs of Alzheimer's and mild cognitive impairment, making it easier for older adults to get the help they need sooner.
-
Using computer speech analysis to diagnose Alzheimer's and other neurocognitive disorders
This study is looking at how computer analysis of speech can help doctors spot early signs of memory problems like Alzheimer's, making it easier for them to help people who might be experiencing these issues.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.